PTGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Protagonist Therapeutics, Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$134.44+5.69 (+4.42%)
Close on Oct 19, 2026
- Market cap
- $9.55B
- P/E (TTM)
- 130.5
- Dividend yield
- –
SEC filings
40 of Protagonist Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2026 | Jun 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 5, 2026 | SEC EDGAR |
| Current report | 8-K | May 5, 2026 | May 5, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 17, 2026 | Apr 28, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 25, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 25, 2026 | Feb 25, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 20, 2025 | Jun 26, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 6, 2025 | SEC EDGAR |
| Current report | 8-K | May 6, 2025 | May 6, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 20, 2025 | Apr 29, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2025 | Mar 20, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 8, 2025 | Mar 10, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2025 | Mar 3, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 21, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 21, 2025 | Feb 21, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 1, 2025 | Jan 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2024 | Nov 18, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 17, 2024 | Sep 20, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 20, 2024 | Jun 26, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 7, 2024 | SEC EDGAR |
| Current report | 8-K | May 7, 2024 | May 7, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 20, 2024 | Apr 26, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Feb 27, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2024 | Feb 27, 2024 | SEC EDGAR |
| Current report | 8-K | Jan 31, 2024 | Jan 31, 2024 | SEC EDGAR |
| Current report | 8-K | Jan 9, 2024 | Jan 16, 2024 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2024 | Jan 8, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 2, 2023 | SEC EDGAR |
| Current report | 8-K | Nov 2, 2023 | Nov 2, 2023 | SEC EDGAR |